Pfizer and BioNTech begin Covid-19 vaccine trial in pregnant women
The Phase 2/3 study will enrol healthy pregnant women, aged 18 years and older, and vaccinate them during…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
19 Feb 21
The Phase 2/3 study will enrol healthy pregnant women, aged 18 years and older, and vaccinate them during…
18 Feb 21
The companies initially signed an agreement in April 2020 to discover and develop new therapies for coronaviruses
17 Feb 21
Entresto benefits patients with both heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection…
16 Feb 21
Plavix is an antiplatelet medication or blood thinner, intended to reduce the risk of heart disease and stroke…
15 Feb 21
Panzyga was previously approved in the US to treat primary humoral immunodeficiency in people aged two years and…
15 Feb 21
The EC approval allows the sale of Ogluo in all 27 European Union (EU) member countries, along with…
12 Feb 21
Sandoz will obtain the global rights to GSK’s three established brands Zinnat, Zinacef and Fortum, in more than…
11 Feb 21
The collaboration will focus on a specific neuroinflammatory pathway associated with the development of AD
11 Feb 21
Crestor is a statin, a lipid-lowering medicine intended to treat blood lipid disorders and prevent cardiovascular events, such…
10 Feb 21
Bamlanivimab plus etesevimab combination is indicated for the treatment of mild to moderate Covid-19 in patients aged 12…